Mymetics Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
7,969.70
4,318.90
3,333.40
6,597.40
4,638.10
4,921.90
Depreciation, Depletion & Amortization
26.60
43.80
47.70
46.50
44.00
34.20
Other Funds
8,265.80
128.70
161.90
2,591.80
40.60
15.30
Funds from Operations
269.50
4,146.50
3,123.80
3,959.10
4,553.50
4,872.40
Changes in Working Capital
5,497.70
8,083.40
3,933.30
2,867.30
1,788.90
2,143.60
Net Operating Cash Flow
5,767.20
3,936.90
809.50
1,091.80
2,764.60
2,728.80
Capital Expenditures
144.70
59.70
22.20
3.30
41.70
Net Investing Cash Flow
144.70
59.70
22.20
3.30
41.70
Issuance/Reduction of Debt, Net
5,841.50
2,040.10
-
-
2,594.30
Net Financing Cash Flow
5,901.30
2,040.10
-
-
2,594.30
Net Change in Cash
14.60
1,746.90
850.50
1,095.10
238.00
Free Cash Flow
5,911.90
3,877.20
787.30
1,095.10
2,806.30
Change in Capital Stock
59.70
-
-
-
-
Exchange Rate Effect
25.20
90.20
63.20
-
25.90

About Mymetics

View Profile
Address
Route de la Corniche 4
Epalinges Vaud 1066
Switzerland
Employees -
Website http://www.mymetics.com
Updated 07/08/2019
Mymetics Corp. is a biotechnology company, which engages in the provision of research and development of vaccines for infectious and life threatening diseases. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland. .